Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Medico Remedies Ltd.

Medico Remedies

NSE

0.00

0.00 (0.00)%

Healthcare

Small-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

7. Ramesh Rughani
Non Executive Independent Director
9. Dinesh Navnitlal Modi
Company Secretary & Compliance Officer
10. Dayanand Shivshankar Mathapati
Executive Director
12. Hasan Bohra
Company Secretary & Compliance Officer
13. Anuj Mody
Non Executive Independent Director

Contact Information

Company Address

1105/1106, 11th Floor, Hubtown Solaris, Opp Telli Galli, N S Phadke Marg, Andheri East
Mumbai, Maharashtra - 400069
www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
medicoremedies@yahoo.com / info@medicoremedies.com

Registrar

Cameo Corporate Services Ltd
304 Sai Sadan 3rd Floor76 - 78 , Mody Street, Fort,Mumbai – 400001Website: www.cameoindia.comTel: 022 - 22644325; Email id - investor@cameoindia.com
Phone: 022 - 22644325
Email: investor@cameoindia.com
Website: www.cameoindia.com

Company Profile

The company was incorporated as Medico Remedies Private Limited on March 18, 1994 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of Company was changed to a public limited company and the name of Company was changed to Medico Remedies Limited by a special resolution passed on January 12, 2017. A fresh Certificate of Incorporation consequent upon conversion was issued on March 06, 2017 by the Registrar of Companies, Mumbai.

They serve wholesalers or traders of formulation products. The company exports its products to Uganda, Myanmar, Vietnam, Cambodia, Dominican Republic, Sri Lanka, Philippines, Turkmenistan, Ghana, Mauritius, Madagascar, Congo, Iraq, Honduras, Cuba, Jamaica, Hong Kong, Nigeria, Senegal, Panama, Mozambique etc. The company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments. Currently, it is engaged in manufacture of formulations for various medicines. Its clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. MRL also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.

Business area of the company:

The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Key Events and Milestones:

  • 1994: Incorporated under Companies Act, 1956 as Medico Remedies Private Limited.
  • 1999: Acquired plot at Palghar for setting up manufacturing set-up for general formulations. 
  • 2002: Acquired plot at Palghar for setting up manufacturing set-up for beta lactam.
  • 2016: Renewed WHO-GMP Certification for their manufacturing facility.
  • 2016: Purchased corporate premises at ‘Hubtown Solaris’.
  • 2017: Renewed ISO-9001:2015 Certification for their manufacturing facility.
  • 2017: Converted into a public limited company and the name of company was changed to Medico Remedies Ltd.
Enrich money logo